Zhang P, Yang L-N, Wang G, Li F-E, Tang F
The Department of Nephrology, 452nd Hospital of the Chinese, People's Liberation Army, Chengdu, China.
The Department of Nephrology, 452nd Hospital of the Chinese, People's Liberation Army, Chengdu, China
Genet Mol Res. 2014 Nov 27;13(4):9883-8. doi: 10.4238/2014.November.27.16.
Hepcidin is a key protein of iron metabolism, which may play an important role in the prognosis of patients with chronic renal failure on maintenance hemodialysis. The purpose of this study was to investigate the relationship between the prognosis of maintenance hemodialysis patients and serum hepcidin level. We enrolled 60 patients on maintenance hemodialysis and 30 healthy controls from March 2012 to December 2012 in our hospital. Peripheral blood samples were collected to determine hepcidin by an ELISA method. Hepcidin levels of hemodialysis patients were significantly higher than those of the healthy control group. Hepcidin level was positively correlated with the degree of anemia in the dialysis group. Therefore, we conclude that hepcidin level is significantly increased in patients with chronic renal failure on maintenance hemodialysis and that increased hepcidin seriously affects the prognosis of chronic renal failure.
铁调素是铁代谢的关键蛋白,可能在维持性血液透析的慢性肾衰竭患者的预后中发挥重要作用。本研究旨在探讨维持性血液透析患者的预后与血清铁调素水平之间的关系。2012年3月至2012年12月,我们纳入了我院60例维持性血液透析患者和30例健康对照者。采集外周血样本,采用酶联免疫吸附测定法(ELISA法)测定铁调素。血液透析患者的铁调素水平显著高于健康对照组。透析组中铁调素水平与贫血程度呈正相关。因此,我们得出结论,维持性血液透析的慢性肾衰竭患者铁调素水平显著升高,且铁调素升高严重影响慢性肾衰竭的预后。